Abstract
Cancer is a lethal disease and is one of the leading causes of morbidity worldwide. Chemotherapy is successful to combat cancer but medical applicability of many chemotherapeutic agents is limited by the non-specific targeting of malignant cells, leading to unwanted side effects. Nanoparticles (NPs) are well-established nano-carriers that can protect drugs from enzymatic degradation and unspecific release in the circulatory system, and deliver it into tumor cells which can modulate pharmacokinetic parameters and therapeutic efficacy of a drug. NPs represent a successful strategy toward targeted drug delivery to treat cancer. The specific characteristics of NPs include biodegradability, non-toxicity, biocompatibility, prolonged circulation time, and a wide range of drug encapsulation capacities. Owing to its small size and spherical shape, it can encapsulate a higher amount of drug and deliver it specifically to the target size, either by passive or by active targeting, and reduce the drug-associated toxicity. Conjugation of specific ligands on the surface of NPs can enhance therapeutic efficacy and reduce unwanted side effects of the drug.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, Hanifehpour Y, Nejati-Koshki K, Pashaei-Asl R (2014) Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett 9(1):247. https://doi.org/10.1186/1556-276X-9-247
Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN (1991) A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol 9(3):491–498. https://doi.org/10.1200/JCO.1991.9.3.491
Adams ML, Lavasanifar A, Kwon GS (2003) Amphiphilic block copolymers for drug delivery. J Pharm Sci 92(7):1343–1355. https://doi.org/10.1002/jps.10397
Alam N, Dubey RD, Kumar A, Koul M, Sharma N, Sharma PR, Chandan BK, Singh SK, Singh G, Gupta PN (2015) Reduced toxicological manifestations of cisplatin following encapsulation in folate grafted albumin nanoparticles. Life Sci 142:76–85. https://doi.org/10.1016/j.lfs.2015.10.019
Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303(5665):1818–1822. https://doi.org/10.1126/science.1095833
Avramovic N, Mandic B, Savic-Radojevic A, Simic T (2020) Polymeric nanocarriers of drug delivery systems in cancer therapy. Pharmaceutics 12(4). https://doi.org/10.3390/pharmaceutics12040298
Bawa R, Melethil S, Simmons WJ, Harris D (2008) Nanopharmaceuticals: patenting issues and FDA regulatory challenges. SciTech Lawyer 5(2):10–15
Bayon-Cordero L, Alkorta I, Arana L (2019) Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs. Nano 9(3). https://doi.org/10.3390/nano9030474
Bertrand N, Leroux J-C (2012) The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release 161(2):152–163. https://doi.org/10.1016/j.jconrel.2011.09.098
Bharali DJ, Lucey DW, Jayakumar H, Pudavar HE, Prasad PN (2005) Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy. J Am Chem Soc 127(32):11364–11371. https://doi.org/10.1021/ja051455x
Bregadze VI, Sivaev IB, Dubey RD, Semioshkin A, Shmal'ko AV, Kosenko ID, Lebedeva KV, Mandal S, Sreejyothi P, Sarkar A, Shen Z, Wu A, Hosmane NS (2020) Boron-containing lipids and liposomes: new conjugates of cholesterol with polyhedral boron hydrides. Chem Eur J 26(61):13832–13841. https://doi.org/10.1002/chem.201905083
Brewer E, Coleman J, Lowman A (2011) Emerging technologies of polymeric nanoparticles in cancer drug delivery. J Nanomater 2011:408675. https://doi.org/10.1155/2011/408675
Burns KE, Delehanty JB (2018) Cellular delivery of doxorubicin mediated by disulfide reduction of a peptide-dendrimer bioconjugate. Int J Pharm 545(1):64–73. https://doi.org/10.1016/j.ijpharm.2018.04.027
Cai W, Gao T, Hong H, Sun J (2008) Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl 1:17
Cho K, Wang X, Nie S, Chen Z, Shin DM (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14(5):1310–1316. https://doi.org/10.1158/1078-0432.CCR-07-1441
Cole AJ, Yang VC, David AE (2011) Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol 29(7):323–332. https://doi.org/10.1016/j.tibtech.2011.03.001
Conde J, Artzi N (2015) Are RNAi and miRNA therapeutics truly dead? Trends Biotechnol 33(3):141–144. https://doi.org/10.1016/j.tibtech.2014.12.005
Cui H, Webber MJ, Stupp SI (2010) Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. Pept Sci 94(1):1–18. https://doi.org/10.1002/bip.21328
Cummings J, McArdle CS (1986) Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug. Br J Cancer 53(6):835–838. https://doi.org/10.1038/bjc.1986.141
Danhier F, Feron O, Preat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148(2):135–146. https://doi.org/10.1016/j.jconrel.2010.08.027
Davis ME, Chen Z, Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7(9):771–782. https://doi.org/10.1038/nrd2614
Decuzzi P, Pasqualini R, Arap W, Ferrari M (2008) Intravascular delivery of particulate systems: does geometry really matter? Pharm Res 26(1):235. https://doi.org/10.1007/s11095-008-9697-x
Dellali KZ, Rata DM, Popa M, Djennad M, Ouagued A, Gherghel D (2020) Antitumoral drug: loaded hybrid nanocapsules based on chitosan with potential effects in breast cancer therapy. Int J Mol Sci 21(16):5659. https://doi.org/10.3390/ijms21165659
Dellian M, Yuan F, Trubetskoy VS, Torchilin VP, Jain RK (2000) Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer 82(9):1513–1518. https://doi.org/10.1054/bjoc.1999.1171
Dhar S, Liu Z, Thomale J, Dai H, Lippard SJ (2008) Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc 130(34):11467–11476. https://doi.org/10.1021/ja803036e
Dilnawaz F (2019) Multifunctional mesoporous silica nanoparticles for cancer therapy and imaging. Curr Med Chem 26(31):5745–5763. https://doi.org/10.2174/0929867325666180501101044
Duan Y, Sun X, Gong T, Wang Q, Zhang Z (2006) Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo. J Mater Sci Mater Med 17(6):509–516. https://doi.org/10.1007/s10856-006-8933-3
Dubey RD, Alam N, Saneja A, Khare V, Kumar A, Vaidh S, Mahajan G, Sharma PR, Singh SK, Mondhe DM, Gupta PN (2015) Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine. Int J Pharm 492(1):80–91. https://doi.org/10.1016/j.ijpharm.2015.07.012
Dubey RD, Klippstein R, Wang JT-W, Hodgins N, Mei K-C, Sosabowski J, Hider RC, Abbate V, Gupta PN, Al-Jamal KT (2017) Novel hyaluronic acid conjugates for dual nuclear imaging and therapy in CD44-expressing tumors in mice in vivo. Nano 1(1):59–79. https://doi.org/10.7150/ntno.17896
Dubey RD, Saneja A, Gupta PK, Gupta PN (2016a) Recent advances in drug delivery strategies for improved therapeutic efficacy of gemcitabine. Eur J Pharm Sci 93:147–162. https://doi.org/10.1016/j.ejps.2016.08.021
Dubey RD, Saneja A, Qayum A, Singh A, Mahajan G, Chashoo G, Kumar A, Andotra SS, Singh SK, Singh G, Koul S, Mondhe DM, Gupta PN (2016b) PLGA nanoparticles augmented the anticancer potential of pentacyclictriterpenediol in vivo in mice. RSC Adv 6(78):74586–74597. https://doi.org/10.1039/C6RA14929D
Dubey RD, Sarkar A, Shen Z, Bregadze VI, Sivaev IB, Druzina AA, Zhidkova OB, Shmal'ko AV, Kosenko ID, Mandal S, Hosmane NS (2021) Effects of linkers on the development of liposomal formulation of cholesterol conjugated cobalt Bis(dicarbollides). J Pharm Sci 110(3):1365–1373. https://doi.org/10.1016/j.xphs.2020.12.017
Elhissi AM, Ahmed W, Hassan IU, Dhanak VR, D'Emanuele A (2012) Carbon nanotubes in cancer therapy and drug delivery. J Drug Deliv 2012:837327. https://doi.org/10.1155/2012/837327
Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63(3):136–151. https://doi.org/10.1016/j.addr.2010.04.009
Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR (2019) Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine 14(1):93–126
Farokhzad OC, Langer R (2009) Impact of nanotechnology on drug delivery. ACS Nano 3(1):16–20. https://doi.org/10.1021/nn900002m
Gabizon AA (1992) Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52(4):891–896
Garcia-Pinel B, Porras-Alcala C, Ortega-Rodriguez A, Sarabia F, Prados J, Melguizo C, Lopez-Romero JM (2019) Lipid-based nanoparticles: application and recent advances in cancer treatment. Nano 9(4). https://doi.org/10.3390/nano9040638
Gleich B, Weizenecker J (2005) Tomographic imaging using the nonlinear response of magnetic particles. Nature 435(7046):1214–1217. https://doi.org/10.1038/nature03808
Grigore ME, Holban AM, Grumezescu AM (2017) Chapter 9 - Nanotherapeutics in the management of infections and cancer. In: Razavi M, Thakor A (eds) Nanobiomaterials science, Development and Evaluation. Woodhead Publishing, Duxford, pp 163–189
GuneyEskiler G, Cecener G, Egeli U, Tunca B (2018) Synthetically lethal BMN 673 (Talazoparib) loaded solid lipid nanoparticles for BRCA1 mutant triple negative breast cancer. Pharm Res 35(11):218. https://doi.org/10.1007/s11095-018-2502-6
Gupta PN, Jain S, Nehate C, Alam N, Khare V, Dubey RD, Saneja A, Kour S, Singh SK (2014) Development and evaluation of paclitaxel loaded PLGA:poloxamer blend nanoparticles for cancer chemotherapy. Int J Biol Macromol 69:393–399. https://doi.org/10.1016/j.ijbiomac.2014.05.067
ten Hagen TL, Seynhaeve AL, van Tiel ST, Ruiter DJ, Eggermont AM (2002) Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats. Int J Cancer 97(1):115–120. https://doi.org/10.1002/ijc.1578
Haley B, Frenkel E (2008) Nanoparticles for drug delivery in cancer treatment. Urol Oncol 26(1):57–64. https://doi.org/10.1016/j.urolonc.2007.03.015
Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348(25):2491–2499. https://doi.org/10.1056/NEJMoa022749
Harris JM, Martin NE, Modi M (2001a) Pegylation. Clin Pharmacokinet 40(7):539–551. https://doi.org/10.2165/00003088-200140070-00005
Harris JM, Martin NE, Modi M (2001b) Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40(7):539–551. https://doi.org/10.2165/00003088-200140070-00005
Herizchi R, Abbasi E, Milani M, Akbarzadeh A (2016) Current methods for synthesis of gold nanoparticles. Artif Cells Nanomed Biotechnol 44(2):596–602. https://doi.org/10.3109/21691401.2014.971807
Hild WA, Breunig M, Goepferich A (2008) Quantum dots - nano-sized probes for the exploration of cellular and intracellular targeting. Eur J Pharm Biopharm 68(2):153–168. https://doi.org/10.1016/j.ejpb.2007.06.009
Hu J, Su Y, Zhang H, Xu T, Cheng Y (2011) Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery. Biomaterials 32(36):9950–9959. https://doi.org/10.1016/j.biomaterials.2011.09.016
Hureaux J, Lagarce F, Gagnadoux F, Vecellio L, Clavreul A, Roger E, Kempf M, Racineux J-L, Diot P, Benoit J-P, Urban T (2009) Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel. Eur J Pharm Biopharm 73(2):239–246. https://doi.org/10.1016/j.ejpb.2009.06.013
Imae T (2012) Physicochemical properties of dendrimers and dendrimer complexes. In: Dendrimer‐based drug delivery systems: from theory to practice. Wiley, Hoboken, pp 55–92. https://doi.org/10.1002/9781118275238.ch2
Jadidi-Niaragh F, Atyabi F, Rastegari A, Kheshtchin N, Arab S, Hassannia H, Ajami M, Mirsanei Z, Habibi S, Masoumi F, Noorbakhsh F, Shokri F, Hadjati J (2017) CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. J Control Release 246:46–59. https://doi.org/10.1016/j.jconrel.2016.12.012
Kesharwani P, Amin MCIM, Giri N, Jain A, Gajbhiye V (2017) Chapter 11 - Dendrimers in targeting and delivery of drugs. In: Mishra V, Kesharwani P, Mohd Amin MCI, Iyer A (eds) Nanotechnology-based approaches for targeting and delivery of drugs and genes. Academic Press, Amsterdam, pp 363–388
Klippstein R, Wang JT, El-Gogary RI, Bai J, Mustafa F, Rubio N, Bansal S, Al-Jamal WT, Al-Jamal KT (2015) Passively targeted curcumin-loaded PEGylated PLGA nanocapsules for colon cancer therapy in vivo. Small 11(36):4704–4722. https://doi.org/10.1002/smll.201403799
Koenig SH, Kellar KE (1995) Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med 34(2):227–233. https://doi.org/10.1002/mrm.1910340214
Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108(6):2064–2110. https://doi.org/10.1021/cr068445e
Lim Z-ZJ, Li J-EJ, Ng C-T, Yung L-YL, Bay B-H (2011) Gold nanoparticles in cancer therapy. Acta Pharmacol Sin 32(8):983–990. https://doi.org/10.1038/aps.2011.82
Liu Z, Chen K, Davis C, Sherlock S, Cao Q, Chen X, Dai H (2008) Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 68(16):6652–6660. https://doi.org/10.1158/0008-5472.CAN-08-1468
Lu Y, Low PS (2002) Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol Immunother 51(3):153–162. https://doi.org/10.1007/s00262-002-0266-6
Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science (New York, NY) 307(5709):538–544. https://doi.org/10.1126/science.1104274
Mochida Y, Cabral H, Kataoka K (2017) Polymeric micelles for targeted tumor therapy of platinum anticancer drugs. Expert Opin Drug Deliv 14(12):1423–1438. https://doi.org/10.1080/17425247.2017.1307338
Moghimi SM, Szebeni J (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42(6):463–478. https://doi.org/10.1016/S0163-7827(03)00033-X
Mudshinge SR, Deore AB, Patil S, Bhalgat CM (2011) Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J 19(3):129–141. https://doi.org/10.1016/j.jsps.2011.04.001
Mukherjee S, Liang L, Veiseh O (2020) Recent advancements of magnetic nanomaterials in cancer therapy. Pharmaceutics 12(2). https://doi.org/10.3390/pharmaceutics12020147
Mydin RBS, Moshawih S (2019) Nanoparticles in nanomedicine application: lipid-based nanoparticles and their safety concerns nanotechnology: applications in energy, drug and food. Springer, pp 227–232
Nacev A, Beni C, Bruno O, Shapiro B (2010) Magnetic nanoparticle transport within flowing blood and into surrounding tissue. Nanomedicine 5(9):1459–1466. https://doi.org/10.2217/nnm.10.104
Najafi-Hajivar S, Zakeri-Milani P, Mohammadi H, Niazi M, Soleymani-Goloujeh M, Baradaran B, Valizadeh H (2016) Overview on experimental models of interactions between nanoparticles and the immune system. Biomed Pharmacother 83:1365–1378. https://doi.org/10.1016/j.biopha.2016.08.060
Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD (1996) Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi’s sarcoma. J Clin Pharmacol 36(1):55–63. https://doi.org/10.1002/j.1552-4604.1996.tb04152.x
Oliveira RR, Carriao MS, Pacheco MT, Branquinho LC, de Souza ALR, Bakuzis AF, Lima EM (2018) Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia. Mater Sci Eng C Mater Biol Appl 92:547–553. https://doi.org/10.1016/j.msec.2018.07.011
Ozturk K, Esendagri G (2017) Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers. Int J Pharm 517(1):157–167. https://doi.org/10.1016/j.ijpharm.2016.12.009
Ozturk K, Esendagli G, Gurbuz MU, Tulu M, Calis S (2017) Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers. Int J Pharm 517(1-2):157–167. https://doi.org/10.1016/j.ijpharm.2016.12.009
Palombo M, Deshmukh M, Myers D, Gao J, Szekely Z, Sinko PJ (2014) Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery. Annu Rev Pharmacol Toxicol 54(1):581–598. https://doi.org/10.1146/annurev-pharmtox-010611-134615
Paroha S, Chandel AKS, Dubey RD (2018) Nanosystems for drug delivery of coenzyme Q10. Environ Chem Lett 16(1):71–77. https://doi.org/10.1007/s10311-017-0664-9
Paroha S, Dewangan RP, Dubey RD, Sahoo PK (2020) Conventional and nanomaterial-based techniques to increase the bioavailability of therapeutic natural products: a review. Environ Chem Lett 18(6):1767–1778. https://doi.org/10.1007/s10311-020-01038-1
Paroha S, Verma J, Dubey RD, Dewangan RP, Molugulu N, Bapat RA, Sahoo PK, Kesharwani P (2021) Recent advances and prospects in gemcitabine drug delivery systems. Int J Pharm 592:120043. https://doi.org/10.1016/j.ijpharm.2020.120043
Pasqua L, Leggio A, Sisci D, Ando S, Morelli C (2016) Mesoporous silica nanoparticles in cancer therapy: relevance of the targeting function. Mini Rev Med Chem 16(9):743–753. https://doi.org/10.2174/1389557516666160321113620
Patil Y, Sadhukha T, Ma L, Panyam J (2009) Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. J Control Release 136(1):21–29. https://doi.org/10.1016/j.jconrel.2009.01.021
Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9(8):615–627. https://doi.org/10.1038/nrd2591
Pirollo KF, Chang EH (2008) Does a targeting ligand influence nanoparticle tumor localization or uptake? Trends Biotechnol 26(10):552–558
Probst CE, Zrazhevskiy P, Bagalkot V, Gao X (2013) Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev 65(5):703–718. https://doi.org/10.1016/j.addr.2012.09.036
Rizvi SAA, Saleh AM (2018) Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J 26(1):64–70. https://doi.org/10.1016/j.jsps.2017.10.012
Saneja A, Arora D, Kumar R, Dubey RD, Panda AK, Gupta PN (2018a) CD44 targeted PLGA nanomedicines for cancer chemotherapy. Eur J Pharm Sci 121:47–58. https://doi.org/10.1016/j.ejps.2018.05.012
Saneja A, Arora D, Kumar R, Dubey RD, Panda AK, Gupta PN (2018b) Therapeutic applications of betulinic acid nanoformulations. Ann N Y Acad Sci 1421(1):5–18. https://doi.org/10.1111/nyas.13570
Saneja A, Kumar R, Mintoo MJ, Dubey RD, Sangwan PL, Mondhe DM, Panda AK, Gupta PN (2019) Gemcitabine and betulinic acid co-encapsulated PLGA–PEG polymer nanoparticles for improved efficacy of cancer chemotherapy. Mater Sci Eng C 98:764–771. https://doi.org/10.1016/j.msec.2019.01.026
Saneja A, Kumar R, Singh A, Dhar Dubey R, Mintoo MJ, Singh G, Mondhe DM, Panda AK, Gupta PN (2017a) Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Int J Pharm 531(1):153–166. https://doi.org/10.1016/j.ijpharm.2017.08.076
Saneja A, Sharma L, Dubey RD, Mintoo MJ, Singh A, Kumar A, Sangwan PL, Tasaduq SA, Singh G, Mondhe DM, Gupta PN (2017b) Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate. Mater Sci Eng C 73:616–626. https://doi.org/10.1016/j.msec.2016.12.109
Shi J, Kantoff PW, Wooster R, Farokhzad OC (2017) Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17(1):20–37. https://doi.org/10.1038/nrc.2016.108
Singh A, Patel T, Hertel J, Bernardo M, Kausz A, Brenner L (2008) Safety of ferumoxytol in patients with anemia and CKD. Am J Kidney Dis 52(5):907–915. https://doi.org/10.1053/j.ajkd.2008.08.001
Smith AM, Nie S (2010) Semiconductor nanocrystals: structure, properties, and band gap engineering. Acc Chem Res 43(2):190–200. https://doi.org/10.1021/ar9001069
Son KH, Hong JH, Lee JW (2016) Carbon nanotubes as cancer therapeutic carriers and mediators. Int J Nanomedicine 11:5163–5185. https://doi.org/10.2147/IJN.S112660
Son KJ, Yoon HJ, Kim JH, Jang WD, Lee Y, Koh WG (2011) Photosensitizing hollow nanocapsules for combination cancer therapy. Angew Chem 50(50):11968–11971. https://doi.org/10.1002/anie.201102658
Soo Choi H, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV (2007) Renal clearance of quantum dots. Nat Biotechnol 25(10):1165–1170. https://doi.org/10.1038/nbt1340
Sun C, Lee JS, Zhang M (2008) Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 60(11):1252–1265. https://doi.org/10.1016/j.addr.2008.03.018
Talelli M, Rijcken CJF, Hennink WE, Lammers T (2012) Polymeric micelles for cancer therapy: 3 C’s to enhance efficacy. Curr Opinion Solid State Mater Sci 16(6):302–309. https://doi.org/10.1016/j.cossms.2012.10.003
Torchilin V (2011) Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63(3):131–135. https://doi.org/10.1016/j.addr.2010.03.011
Varela-Moreira A, Shi Y, Fens MHAM, Lammers T, Hennink WE, Schiffelers RM (2017) Clinical application of polymeric micelles for the treatment of cancer. Mater Chem Front 1(8):1485–1501. https://doi.org/10.1039/C6QM00289G
Wan D, Li C, Pan J (2020) Polymeric micelles with reduction-responsive function for targeted cancer chemotherapy. ACS Appl Bio Mater 3(2):1139–1146. https://doi.org/10.1021/acsabm.9b01070
Wang J, Li S, Han Y, Guan J, Chung S, Wang C, Li D (2018) Poly(ethylene glycol)–polylactide micelles for cancer therapy. Front Pharmacol 9(202). https://doi.org/10.3389/fphar.2018.00202
Webster DM, Sundaram P, Byrne ME (2013) Injectable nanomaterials for drug delivery: carriers, targeting moieties, and therapeutics. Eur J Pharm Biopharm 84(1):1–20. https://doi.org/10.1016/j.ejpb.2012.12.009
Wisse E, Braet F, Luo D, De Zanger R, Jans D, Crabbe E, Vermoesen A (1996) Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol 24(1):100–111
Wu W, Li R, Bian X, Zhu Z, Ding D, Li X, Jia Z, Jiang X, Hu Y (2009) Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity. ACS Nano 3(9):2740–2750. https://doi.org/10.1021/nn9005686
Xiong Z, Shen M, Shi X (2018) Dendrimer-based strategies for cancer therapy: recent advances and future perspectives. Sci China Mater 61(11):1387–1403. https://doi.org/10.1007/s40843-018-9271-4
Yameen B, Choi WI, Vilos C, Swami A, Shi J, Farokhzad OC (2014) Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release 190:485–499. https://doi.org/10.1016/j.jconrel.2014.06.038
Yang F, Hu J, Yang D, Long J, Luo G, Jin C, Yu X, Xu J, Wang C, Ni Q, Fu D (2009) Pilot study of targeting magnetic carbon nanotubes to lymph nodes. Nanomedicine 4(3):317–330. https://doi.org/10.2217/nnm.09.5
Yang Y, Jing L, Li X, Lin L, Yue X, Dai Z (2017) Hyaluronic acid conjugated magnetic Prussian blue@quantum dot nanoparticles for cancer theranostics. Theranostics 7(2):466–481. https://doi.org/10.7150/thno.17411
Yoo HS, Park TG (2004) Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 96(2):273–283. https://doi.org/10.1016/j.jconrel.2004.02.003
Yu G, Ning Q, Mo Z, Tang S (2019) Intelligent polymeric micelles for multidrug co-delivery and cancer therapy. Artif Cells Nanomed Biotechnol 47(1):1476–1487. https://doi.org/10.1080/21691401.2019.1601104
Yurgel V, Collares T, Seixas F (2013) Developments in the use of nanocapsules in oncology. Braz J Med Biol Res 46(6):486–501. https://doi.org/10.1590/1414-431X20132643
Zhang Z, Feng S-S (2006) Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 27(2):262–270. https://doi.org/10.1016/j.biomaterials.2005.05.104
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Paroha, S. et al. (2023). Nanoparticles for Targeted Drug Delivery Systems with Cancer Therapy in Perspective. In: Rajput, V.S., Runthala, A. (eds) Drugs and a Methodological Compendium . Springer, Singapore. https://doi.org/10.1007/978-981-19-7952-1_11
Download citation
DOI: https://doi.org/10.1007/978-981-19-7952-1_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-7951-4
Online ISBN: 978-981-19-7952-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)